08:00 , Jan 24, 2011 |  BC Week In Review  |  Company News

Pharmstandard, Biolek PJSC deal

Pharmaceutical company Pharmstandard acquired a 55% stake in Biolek. The acquisition will add vaccines and oncology drugs to Pharmstandard's portfolio and increase its sales presence in Russia. Further terms were not disclosed. Pharmstandard OJSC (RTS:PHST;...